Cite
HARVARD Citation
Emery, P. et al. (2017). Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4. Annals of the rheumatic diseases. 76 (12), pp. 1986-1991. [Online].